According to GuruFocus Insider Data, these are the largest CEO buys during the past week.
American Assets Trust CEO bought 199,256 shares
American Assets Trust Inc. (AAT, Financial) Chairman, CEO, President, and 10% Owner Ernest S. Rady bought 199,256 shares during the past week at a price of $32.49.
American Assets Trust is a self-administered real estate investment trust based in the U.S. The company mainly invests in, operates and develops retail, office, residential and mixed-use properties in California, Oregon and Hawaii. The company has a market cap of $2.11 billion. Its shares traded at $32.71 with a price-earnings (P/E) ratio of 52.59 as of Feb. 23.
Net income for the fourth quarter of 2017 was $9.73 million compared to $12.41 million for the prior-year period.
Rady bought 94,155 shares on Feb. 21 at a price of $32.31 and 105,101 shares on Feb. 23 at a price of $32.65. The price of the stock has increased by 0.18% since.
Odonate Therapeutics CEO bought 167,338 shares
Odonate Therapeutics Inc. (ODT, Financial) CEO and 10% Owner Kevin C. Tang bought 167,338 shares during the past week at a price of $23.57.
Odonate Therapeutics is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer. The company has a market cap of $769.93 million. Its shares traded at $28.17 as of Feb. 23.
Net loss for the three months ended Dec. 31, 2017, was $15.7 million compared to $1.9 million for the same period in 2016.
On Dec. 11, 2017, Odonate announced the closing of its initial public offering of 6.25 million shares of common stock at a public offering price of $24.00 per share.
Tang bought 128,255 shares on Feb. 16 at a price of $22.47 and 39,083 shares on Feb. 22 at a price of $27.17. The price of the stock has increased by 3.68% since.
Zimmer Biomet Holdings CEO bought 25,077 shares
Zimmer Biomet Holdings Inc. (ZBH, Financial) President and CEO Bryan C. Hanson bought 25,077 shares on Feb.20 at a price of $119.68. The price of the stock has decreased by 0.69% since.
Zimmer Biomet Holdings is a medical device company. It designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery under brands like NexGen, VerSys, SoPlus, and Pulsavac. The company has a market cap of $24.10 billion. Its shares traded at $118.85 with a price-earnings (P/E) ratio of 13.16 as of Feb. 23.
Net sales for the fourth quarter of 2017 were $2.07 billion.
Senior Vice President, General Counsel and Secretary Chad F. Phipps sold 20,826 shares on Feb. 12 at a price of $115.95. The price of the stock has increased by 2.5% since.
Inphi CEO bought 25,000 shares
Inphi Corp. (IPHI, Financial) President and CEO Ford Tamer bought 25,000 shares on Feb. 23 at a price of $25.54. The price of the stock has increased by 3.01% since.
Inphi is engaged in designing, development and sale of high-speed analog connectivity components that operate to maintain, amplify and improve signal integrity in a wide variety of applications. The company has a market cap of $1.12 billion. Its shares traded at $26.31 as of Feb. 23.
Net income for the fourth quarter of 2017 was almost break-even at $0.1 million, compared with net income of $19.1 million in the fourth quarter of 2016.
CFO John Edmunds sold 108,554 shares on Feb. 15 at a price of $25.25. The price of the stock has increased by 4.2% since.
Director Sam Srinivasan bought 5,000 shares on Feb. 16 at a price of $24.93. The price of the stock has increased by 5.54% since.
OPKO Health CEO bought 172,500 shares
OPKO Health Inc. (OPK, Financial) CEO, Chairman, and 10% Owner Phillip Frost bought 172,500 shares on Feb. 21 at a price of $3.63.
OPKO is a diversified health care company. Its business includes diagnostics and provision of pharmaceutical products. The company has a market cap of $2.13 billion. Its shares traded at $3.80 as of Feb. 23.
Net loss for the three months ended Sept. 30, 2017, was $46.44 million compared to $14.98 million for the prior-year period.
Frost bought 60,000 shares on Feb. 6 at a price of $4.22; 78,000 shares on Feb. 7 at a price of $4.22; 20,000 shares on Feb. 8 at a price of $4.04; 185,000 shares on Feb. 9 at a price of $3.83; and 172,500 shares on Feb. 21 at a price of $3.63. The price of the stock has increased by 4.68% since.
For the complete list of stocks that bought by their company CEOs, go to: CEO Buys.
Disclosure: I do not own stock in any of the companies mentioned in the article.
